Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

The Development of Acute Gvhd Under Steroid Administration Is a Risk Factor for Non-Relpase Mortality in Patients with Acute Gvhd after Allogeneic Hematopoietic Cell Transplantation

Tatsuya Suwabe, Takayuki Katagiri, Kyoko Fuse, Yasuhiko Shibasaki, Takashi Ushiki, Hirohito Sone, Masayoshi Masuko

Blood (2024) 144 (Supplement 1): 7365.

https://doi.org/10.1182/blood-2024-207321

Published: 2024

Journal Articles

Moderate Immunopeptidome Disparity of HLA-DRB1 in HLA-Mismatched Hematopoietic Stem Cell Transplantation Increases Acute Graft-Versus-Host Disease but Tends to Improve Survival

Kyoko Fuse, Tatuya Suwabe, Takayuki Katagiri, Yasuhiko Shibasaki, Hirohito Sone, Masayoshi Masuko

Blood (2024) 144 (Supplement 1): 2157.

https://doi.org/10.1182/blood-2024-203102

Published: 2024

Journal Articles

Impact of CD34/CD3 Ratio in Graft on the Outcome of Ptcy-Haplo PBSCT

Takayuki Katagiri, Tatsuya Suwabe, Kyoko Fuse, Yasuhiko Shibasaki, Jun Takizawa, Hirohito Sone, Masayoshi Masuko

Blood (2024) 144 (Supplement 1): 7341.

https://doi.org/10.1182/blood-2024-207415

Published: 2024

Journal Articles

Effect of Immunopeptidome Gap Caused By Recipient-Donor HLA Mismatch in Umbilical Cord Blood Transplantation and HLA-Haploidentical Hematopoietic Stem Cell Transplantation

Kyoko Fuse, Tatuya Suwabe, Takayuki Katagiri, Yasuhiko Shibasaki, Hirohito Sone, Masayoshi Masuko

Blood (2023) 142 (Supplement 1): 2183.

https://doi.org/10.1182/blood-2023-184381

Published: 2023

Journal Articles

PB CD8 T N and CD4 T EM on day30 after Allo-HSCT Is a Predictive Marker for the Development of aGVHD

Takayuki Katagiri, Tatuya Suwabe, Kyoko Fuse, Yasuhiko Shibasaki, Jun Takizawa, Hirohito Sone, Masayoshi Masuko

Blood (2023) 142 (Supplement 1): 3571.

https://doi.org/10.1182/blood-2023-183078

Published: 2023

Journal Articles

HLA-B Leader Mismatch Positively Correlates with Survival Rate in Haplo and Cord Blood Transplantation for Acute Leukemia in Japanese Patients

Takayuki Katagiri, Tatsuya Suwabe, Kyoko Fuse, Yasuhiko Shibasaki, Hirohito Sone, Masayoshi Masuko

Blood (2022) 140 (Supplement 1): 7761–7762.

https://doi.org/10.1182/blood-2022-165740

Published: 2022

Journal Articles

Breadth of the Human Leukocyte Antigens Class I Immunopeptidome in Allogenic Hematopoietic Stem Cell Transplantation Outcomes for Myeloid Malignancy

Kyoko Fuse, Tatsuya Suwabe, Takayuki Katagiri, Yasuhiko Shibasaki, Hirohito Sone, Masayoshi Masuko

Blood (2022) 140 (Supplement 1): 4810–4812.

https://doi.org/10.1182/blood-2022-168616

Published: 2022

Journal Articles

The Diversity of Long-Term Persistent WT1-Specific Cytotoxic T Lymphocytes after Wilms' Tumor 1 Peptide Vaccination

Tatsuya Suwabe, Yasuhiko Shibasaki, Suguru Tamura, Takayuki Katagiri, Kyoko Fuse, Takashi Ushiki, Hirohito Sone, Miwako Narita, Masayoshi Masuko

Blood (2021) 138 (Supplement 1): 3578.

https://doi.org/10.1182/blood-2021-146856

Published: 2021

Journal Articles

Stratification of Intermediate-Risk Acute Myeloid Leukemia According to the Expression Level of WT1 mRNA at Diagnosis

Kyoko Fuse, Kaihatsu Akane, Toshiki Kitajima, Akihito Momoi, Takuya Kasami, Takayuki Katagiri, Yasuhiko Shibasaki, Tatsuo Furukawa, Miwako Narita, Hirohito Sone, Masayoshi Masuko

Blood (2021) 138 (Supplement 1): 1286.

https://doi.org/10.1182/blood-2021-146114

Published: 2021

Journal Articles

YAP/TAZ Promote Hematopoietic Regeneration Via Accelerating the Recovery of Bone Marrow Niche

Shun Uemura, Masayuki Yamashita, Ayako Aihara, Takumi Iwawaki, Shuhei Koide, Yaeko Nakajima-Takagi, Motohiko Oshima, Masayoshi Masuko, Jun Takizawa, Hirohito Sone, Taito Nishino, Atsushi Iwama

Blood (2021) 138 (Supplement 1): 199.

https://doi.org/10.1182/blood-2021-148212

Published: 2021

Journal Articles

Easix-1yearas a Prognostic Index for Late Non-Relapse Mortality after Allogenichematopoietic Cell Transplantation

Rui Carrie Takeda, Yasuhiko Shibasaki, Takayuki Katagiri, Kyoko Fuse, Hirohito Sone, Masayoshi Masuko

Blood (2021) 138 (Supplement 1): 4888.

https://doi.org/10.1182/blood-2021-147888

Published: 2021

Journal Articles

Genetic Manipulation Resulting in Decreased Donor Chondroitin sulfate Synthesis Mitigates Gvhd Following Allogeneic Hematopoietic Cell Transplantation in a Murine Model.

Suguru Tamura, MD, Takashi Ushiki, MD PhD, Tatsuya Suwabe, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD, Kyoko Fuse, MD PhD, Yasuhiko Shibasaki, MD PhD, Miwako Narita, MD PhD, Michihiro Igarashi, MDPhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-137448

Published: 2020

Journal Articles

Depletion of Pre-Transplant Skeletal Muscle Is a Significant Poor Prognostic Factor in Allogeneic Hematopoietic Cell Transplantation

Yasuhiko Shibasaki, MD, Kenta Kobayashi, Tatsuya Suwabe, MD, Kyoko Fuse, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD

Blood (2019) 134 (Supplement_1): 3322.

https://doi.org/10.1182/blood-2019-124733

Published: 2019

Journal Articles

Distinct Effects of Chondroitin Sulfate on Hematopoietic Cells and the Stromal Microenvironment in Bone Marrow Hematopoiesis

Takayuki Katagiri, MD, Takashi Ushiki, MD PhD, Asami Kawasaki, PhD, Shun Uemura, MD, Tatsuya Suwabe, MD, Tomoyuki Tanaka, MD PhD, Kyoko Fuse, MD, Yasuhiko Shibasaki, MD, Hirohito Sone, MD PhD, Michihiro Igarashi, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 3852.

https://doi.org/10.1182/blood-2018-99-115796

Published: 2018

Journal Articles

Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT

Kyoko Fuse, MD, Tomoyuki Tanaka, MD PhD, Shun Uemura, MD, Tatsuya Suwabe, MD, Takayuki Katagiri, MD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Tastuo Furukawa, MD PhD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 5260.

https://doi.org/10.1182/blood-2018-99-113251

Published: 2018

Journal Articles

Clinical Features and Risk Factors of Post-Engraftment Bloodstream Infection in Allogeneic HCT

Tatsuya Suwabe, MD, Kyoko Fuse, MD, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD PhD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2018) 132 (Supplement 1): 5712.

https://doi.org/10.1182/blood-2018-99-115844

Published: 2018

Journal Articles

Patient-Based Prediction Algorithm of Relapse after Allo-HSCT for Acute Leukemia Using Machine Learning Approach

Kyoko Fuse, MD, Shun Uemura, MD, Tatsuya Suwabe, MD, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD, Takashi Ushiki, MD PhD, Yasuhiko Shibasaki, MD PhD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Tastuo Furukawa, MD PhD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2017) 130 (Supplement 1): 2044.

https://doi.org/10.1182/blood.V130.Suppl_1.2044.2044

Published: 2017

Journal Articles

Further Prognostic Factors for Stratification of Patients in the High-Risk HCT-CI Group Undergoing Allogeneic HCT

Yasuhiko Shibasaki, MD PhD, Tatsuya Suwabe, MD, Shun Uemura, MD, Takayuki Katagiri, MD, Tomoyuki Tanaka, MD, Takashi Ushiki, MD PhD, Kyoko Fuse, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2017) 130 (Supplement 1): 4590.

https://doi.org/10.1182/blood.V130.Suppl_1.4590.4590

Published: 2017

Journal Articles

Evaluation of Liver Iron Deposition in Transfusion-Dependent Patients By Dual-Energy CT

Hironori Kobayashi, MD PhD, Norihiko Yoshimura, MD PhD, Takayuki Katagiri, MD, Takashi Ushiki, MD PhD, Kyoko Fuse, MD, Yasuhiko Shibasaki, MD PhD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD

Blood (2016) 128 (22): 3619.

https://doi.org/10.1182/blood.V128.22.3619.3619

Published: 2016

Journal Articles

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Kyoko Fuse, MD, Takayuki Katagiri, MD, Yasuhiko Shibasaki, MD PhD, Tomoyuki Tanaka, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD PhD, Tatsuo Furukawa, MD PhD, Naoko Sato, MD PhD, Toshio Yano, MD PhD, Takashi Kuroha, MD PhD, Shigeo Hashimoto, MD PhD, Takashi Ushiki, MD PhD

Blood (2016) 128 (22): 2297.

https://doi.org/10.1182/blood.V128.22.2297.2297

Published: 2016

NARROW

The Development of Acute Gvhd Under Steroid Administration Is a Risk Factor for Non-Relpase Mortality in Patients with Acute Gvhd after Allogeneic Hematopoietic Cell Transplantation

Moderate Immunopeptidome Disparity of HLA-DRB1 in HLA-Mismatched Hematopoietic Stem Cell Transplantation Increases Acute Graft-Versus-Host Disease but Tends to Improve Survival

Impact of CD34/CD3 Ratio in Graft on the Outcome of Ptcy-Haplo PBSCT

Effect of Immunopeptidome Gap Caused By Recipient-Donor HLA Mismatch in Umbilical Cord Blood Transplantation and HLA-Haploidentical Hematopoietic Stem Cell Transplantation

PB CD8 T N and CD4 T EM on day30 after Allo-HSCT Is a Predictive Marker for the Development of aGVHD

HLA-B Leader Mismatch Positively Correlates with Survival Rate in Haplo and Cord Blood Transplantation for Acute Leukemia in Japanese Patients

Breadth of the Human Leukocyte Antigens Class I Immunopeptidome in Allogenic Hematopoietic Stem Cell Transplantation Outcomes for Myeloid Malignancy

The Diversity of Long-Term Persistent WT1-Specific Cytotoxic T Lymphocytes after Wilms' Tumor 1 Peptide Vaccination

Stratification of Intermediate-Risk Acute Myeloid Leukemia According to the Expression Level of WT1 mRNA at Diagnosis

YAP/TAZ Promote Hematopoietic Regeneration Via Accelerating the Recovery of Bone Marrow Niche

Easix-1yearas a Prognostic Index for Late Non-Relapse Mortality after Allogenichematopoietic Cell Transplantation

Genetic Manipulation Resulting in Decreased Donor Chondroitin sulfate Synthesis Mitigates Gvhd Following Allogeneic Hematopoietic Cell Transplantation in a Murine Model.

Depletion of Pre-Transplant Skeletal Muscle Is a Significant Poor Prognostic Factor in Allogeneic Hematopoietic Cell Transplantation

Distinct Effects of Chondroitin Sulfate on Hematopoietic Cells and the Stromal Microenvironment in Bone Marrow Hematopoiesis

Marker Chromosomes Are a New Cytogenetic Adverse Risk Factor in AML after Allo-HCT

Clinical Features and Risk Factors of Post-Engraftment Bloodstream Infection in Allogeneic HCT

Patient-Based Prediction Algorithm of Relapse after Allo-HSCT for Acute Leukemia Using Machine Learning Approach

Further Prognostic Factors for Stratification of Patients in the High-Risk HCT-CI Group Undergoing Allogeneic HCT

Evaluation of Liver Iron Deposition in Transfusion-Dependent Patients By Dual-Energy CT

The Predictive Factors of Favorable Prognosis after Allo-HSCT for Refractory Acute Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only